Venator Materials has registered an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). The company intends to price its 22.7 million shares in the range of $20 to $22 apiece, with an overallotment option for an additional 3.4 million shares. At the maximum price, the entire offering is valued up to $574.31 million.

After the completion of this offering, Huntsman will continue to control a majority of the voting power of the ordinary shares. As a result, Venator will be a “controlled company.” It intends to list its shares on the New York Stock Exchange under the symbol VNTR.

The underwriters in this offering are Citigroup, Goldman Sachs, Merrill Lynch, JPMorgan, Barclays, Deutsche Bank, UBS Investment Bank, RBC Capital Markets, Moelis, HSBC, Nomura, SunTrust Robinson Humphrey, Academy Securities and Commerzbank.

This leading global manufacturer and marketer of chemical products intends to improve the quality of life for downstream consumers and promote a sustainable future. Its products comprise a broad range of pigments and additives that bring color and vibrancy to buildings, protect and extend product life and reduce energy consumption.

The company markets its products globally to a diversified group of industrial customers through two segments: Titanium Dioxide, which consists of its TiO2 business, and Performance Additives, which consists of its functional additives, color pigments, timber treatment and water treatment businesses.

Venator is a leading global producer in many of these key product lines, including TiO2, color pigments and functional additives, a leading North American producer of timber treatment products and a leading European producer of water treatment products. It operates 27 facilities, employs approximately 4,500 associates worldwide and sells its products in more than 110 countries.

For the 12 months ended March 31, 2017, it had total pro forma revenues of $2,136 million.

The company will not receive any proceeds from this offering.

Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.